137 related articles for article (PubMed ID: 20626043)
81. Trends in cervical cancer incidence and mortality in Oklahoma and the United States, 1999-2013.
Gopalani SV; Janitz AE; Campbell JE
Cancer Epidemiol; 2018 Oct; 56():140-145. PubMed ID: 30176544
[TBL] [Abstract][Full Text] [Related]
82. [Evaluation of the recurrence and residual lesions incidence after loop electroexcisional procedure and cold knife conisation].
Kabzińska-Turek M; Basta A; Stangel-Wójcikiewicz K; Knafel A; Zajac K; Przybylska-Jurecka P; Jach R; Milewicz T
Przegl Lek; 2012; 69(9):658-62. PubMed ID: 23401984
[TBL] [Abstract][Full Text] [Related]
83. Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021).
Ho VKY; Deijen CL; Hemmes B; van Erning FN; Snaebjornsson P; van Triest B; Grotenhuis BA
Int J Cancer; 2024 May; 154(9):1569-1578. PubMed ID: 38151810
[TBL] [Abstract][Full Text] [Related]
84. Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix.
Paul C; Sharples KJ; Baranyai J; Jones RW; Skegg DC
Aust N Z J Obstet Gynaecol; 2018 Jun; 58(3):321-329. PubMed ID: 29405269
[TBL] [Abstract][Full Text] [Related]
85. Histopathological findings for cervical lesions in Malaysian women.
Al-Jashamy K; Al-Naggar RA; San P; Mashani M
Asian Pac J Cancer Prev; 2009; 10(6):1159-62. PubMed ID: 20192603
[TBL] [Abstract][Full Text] [Related]
86. Trends in Lung Cancer Incidence Rates by Histological Type in 1975-2008: A Population-Based Study in Osaka, Japan.
Kinoshita FL; Ito Y; Nakayama T
J Epidemiol; 2016 Nov; 26(11):579-586. PubMed ID: 27150013
[TBL] [Abstract][Full Text] [Related]
87. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
[TBL] [Abstract][Full Text] [Related]
88. Prevalence of cervical intraepithelial neoplasia grades II/III and cervical cancer in patients with cytological diagnosis of atypical squamous cells when high-grade intraepithelial lesions (ASC-H) cannot be ruled out.
Cytryn A; Russomano FB; Camargo MJ; Zardo LM; Horta NM; Fonseca Rde C; Tristão MA; Monteiro AC
Sao Paulo Med J; 2009 Sep; 127(5):283-7. PubMed ID: 20169277
[TBL] [Abstract][Full Text] [Related]
89. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.
Bulk S; Van Kemenade FJ; Rozendaal L; Meijer CJ
J Clin Pathol; 2004 Apr; 57(4):388-93. PubMed ID: 15047743
[TBL] [Abstract][Full Text] [Related]
90. Incidence and costs of cervical intraepithelial neoplasia in the Korean population.
Chang HK; Seo SS; Myong JP; Yu YL; Byun SW
J Gynecol Oncol; 2019 May; 30(3):e37. PubMed ID: 30887758
[TBL] [Abstract][Full Text] [Related]
91. Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.
Rozemeijer K; Naber SK; Penning C; Overbeek LI; Looman CW; de Kok IM; Matthijsse SM; Rebolj M; van Kemenade FJ; van Ballegooijen M
BMJ; 2017 Feb; 356():j504. PubMed ID: 28196844
[No Abstract] [Full Text] [Related]
92. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955-1989, their relation to screening and prediction to the year 2000.
Sigurdsson K; Adalsteinsson S; Ragnarsson J
Int J Cancer; 1991 Jun; 48(4):523-8. PubMed ID: 2045199
[TBL] [Abstract][Full Text] [Related]
93. Prevalence of High-Grade Intraepithelial Neoplasia in Patients with Cytology Presenting Atypical Squamous Cells of Undetermined Significance.
Marcos Lopes AC; Campaner AB; Henrique LQ
Acta Cytol; 2016; 60(2):139-44. PubMed ID: 27215420
[TBL] [Abstract][Full Text] [Related]
94. Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.
Rozemeijer K; Penning C; Siebers AG; Naber SK; Matthijsse SM; van Ballegooijen M; van Kemenade FJ; de Kok IM
Cancer Causes Control; 2016 Jan; 27(1):15-25. PubMed ID: 26458884
[TBL] [Abstract][Full Text] [Related]
95. Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
Lönnberg S; Hansen BT; Haldorsen T; Campbell S; Schee K; Nygård M
Int J Cancer; 2015 Oct; 137(7):1758-64. PubMed ID: 25833121
[TBL] [Abstract][Full Text] [Related]
96. Time Trends Analysis of Cervical Cancer Incidence in Cluj County, Romania, Using Data from a Population-Based Cancer Registry.
Ignat RM; Coza D; Ignat P; Badea RI; Șuteu O
Curr Oncol; 2021 Apr; 28(3):1706-1717. PubMed ID: 33946336
[TBL] [Abstract][Full Text] [Related]
97. Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland.
Keim U; Katalinic A; Holleczek B; Wakkee M; Garbe C; Leiter U
Eur J Cancer; 2023 Apr; 183():60-68. PubMed ID: 36801607
[TBL] [Abstract][Full Text] [Related]
98. The incidence and trends of laryngeal malignancies in Sri Lanka from 2001 to 2019: a Joinpoint analysis of the national cancer database.
Jayarajah U; Jayasinghe R; Fernando A; Seneviratne S
J Egypt Natl Canc Inst; 2023 Feb; 35(1):3. PubMed ID: 36809602
[TBL] [Abstract][Full Text] [Related]
99. Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.
Gravdal BH; Lönnberg S; Skare GB; Sulo G; Bjørge T
BMC Womens Health; 2021 Mar; 21(1):110. PubMed ID: 33736628
[TBL] [Abstract][Full Text] [Related]
100. Incidence and mortality from breast and cervical cancer in a Brazilian town.
Ferreira MDC; Vale DB; Barros MBA
Rev Saude Publica; 2021; 55():67. PubMed ID: 34730748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
